These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2024540)

  • 1. Design and analysis of the HYPREN-trial: safety of enalapril and prazosin in the initial treatment phase of patients with congestive heart failure.
    Hasford J; Bussmann WD; Delius W; Köpcke W; Lehmann K; Weber E
    Z Kardiol; 1991; 80 Suppl 2():21-7. PubMed ID: 2024540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First dose hypotension with enalapril and prazosin in congestive heart failure.
    Hasford J; Bussmann WD; Delius W; Koepcke W; Lehmann K; Weber E
    Int J Cardiol; 1991 Jun; 31(3):287-93. PubMed ID: 1879978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).
    Chockalingam A; Venkatesan S; Subramaniam T; Jagannathan V; Elangovan S; Alagesan R; Gnanavelu G; Dorairajan S; Krishna BP; Chockalingam V;
    Am Heart J; 2004 Apr; 147(4):E19. PubMed ID: 15077102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ACE-inhibition on renal function in severe congestive heart failure.
    Swedberg K
    Z Kardiol; 1991; 80 Suppl 2():50-4. PubMed ID: 2024543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side effects of vasodilator therapy in heart failure: risk of hypotension with ACE inhibitors].
    Kromer EP; Elsner D; Riegger GA
    Z Kardiol; 1991; 80 Suppl 2():11-5. PubMed ID: 2024538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced mortality and morbidity with the use of angiotensin-converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure.
    Yusuf S
    Herz; 1993 Dec; 18 Suppl 1():444-8. PubMed ID: 8125425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypotension followed the first dose of angiotensin-converting enzyme inhibitor in patients with heart failure (a multicenter clinical trial)].
    Moiseev VS; Tereshchenko SN; Aleksandriia LG; Kobalava ZhD
    Ter Arkh; 2001; 73(9):61-6. PubMed ID: 11642085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
    Navookarasu NT; Rahman AR; Abdullah I
    Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CART and logistic regression analyses of risk factors for first dose hypotension by an ACE-inhibitor.
    Hasford J; Ansari H; Lehmann K
    Therapie; 1993; 48(5):479-82. PubMed ID: 8146829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
    Vítovec J; Spinar J
    Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of angiotensin converting enzyme inhibitors in the management of patients with chronic heart failure.
    Packer M; Kukin ML; Neuberg GW; Pinsky DJ; Penn J; Abittan MH
    J Hypertens Suppl; 1989 Sep; 7(5):S33-6. PubMed ID: 2681605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Low-dose enalapril in severe chronic heart failure].
    Brilla CG; Krämer B; Risler T; Seipel L
    Z Kardiol; 1991; 80 Suppl 2():44-9. PubMed ID: 2024542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
    Tsuyuki RT; Yusuf S; Rouleau JL; Maggioni AP; McKelvie RS; Wiecek EM; Wang Y; Pogue J; Teo KK; White M; Avezum A; Latini R; Held P; Lindgren E; Probstfield J
    Can J Cardiol; 1997 Dec; 13(12):1166-74. PubMed ID: 9444298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe electrolyte disorders during the therapy of heart failure with the therapy of heart failure with the ACE-inhibitor enalapril].
    Hess B; Keusch G; Neftel K; Margelist F; Bansky G
    Schweiz Med Wochenschr; 1986 Sep; 116(39):1331-6. PubMed ID: 3022372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
    Lantz P; Enghoff E; Hedlund A; Hägg A
    Scand J Urol Nephrol Suppl; 1984; 79():129-32. PubMed ID: 6089312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.